Friday, May 15, 2020

Aarti Drugs Q4

Aarti Drugs Q4 Revenues down 2% at Rs 450 cr vs Rs 459 cr Net profit up 115% at Rs 58.9 cr vs Rs 27.4 cr EBITDA up 27% at Rs 71.5 cr vs Rs 56.3 cr Margins at 15.9% vs 12.2%  

No comments:

Post a Comment